Gaurav Byagathvalli Gaurav Byagathvalli

Piezo Therapeutics Launches to Transform Delivery of Nucleic Acid Medicines

- Piezo is developing a simple, affordable, and scalable platform designed for rapid, safe, and efficient delivery of nucleic acid medicines, including RNA/DNA vaccines, therapeutic proteins, and dermal gene therapies

- Invented by Georgia Tech researchers, Piezo launches with $2 million in seed funding from Open Philanthropy

Read More

News Articles